| __timestamp | BioCryst Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 122000 | 3243000 |
| Thursday, January 1, 2015 | 1896000 | 2472000 |
| Friday, January 1, 2016 | 2699000 | 2548000 |
| Sunday, January 1, 2017 | 1702000 | 19623000 |
| Monday, January 1, 2018 | 471000 | 30421000 |
| Tuesday, January 1, 2019 | 4101000 | 32793999 |
| Wednesday, January 1, 2020 | 1676000 | 28304000 |
| Friday, January 1, 2021 | 7264000 | 620000 |
| Saturday, January 1, 2022 | 6594000 | 755000 |
| Sunday, January 1, 2023 | 4661000 | 1322000 |
Infusing magic into the data realm
In the competitive world of biotechnology, cost efficiency can be a decisive factor for success. BioCryst Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. have shown contrasting trends in their cost of revenue from 2014 to 2023. BioCryst's cost of revenue peaked in 2021, reaching approximately 7.3 million, while Viridian's highest was in 2019, with a staggering 32.8 million. Interestingly, BioCryst managed to reduce its costs by about 36% from 2021 to 2023, whereas Viridian saw a significant drop of nearly 96% from 2019 to 2021. This data highlights the dynamic nature of cost management strategies in the biotech sector. As these companies navigate the complexities of drug development and market demands, their ability to optimize costs will be crucial for long-term sustainability and growth.
Cost of Revenue Trends: Sanofi vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for GSK plc and Viridian Therapeutics, Inc.
Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Incyte Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs BioCryst Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Vericel Corporation vs BioCryst Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Geron Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.